The use of ioxaglate in the paediatric gastrointestinal tract: a report of 25 cases.
There are recognised dangers in the use of either barium sulphate suspensions or the conventional hypertonic water-soluble contrast media in the gastrointestinal tract which can be avoided by the use of water-soluble contrast media isosmolar with plasma. This paper reports the satisfactory use of ioxaglate (Hexabrix) in solutions with osmolality of 290 mosmol/kg (160 mg I/ml) and it is proposed that isosmolar water-soluble contrast media could be usefully used in all at-risk children. In one case with hypertrophic pyloric stenosis there was no delay in the passage of isosmolar ioxaglate through the hypertrophied pylorus.
D000293:Adolescent; D002675:Child, Preschool; D003287:Contrast Media; D005260:Female; D005767:Gastrointestinal Diseases / Q000000981:diagnostic imaging*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007463:Iodobenzoates; D007485:Ioxaglic Acid; D008297:Male; D009994:Osmolar Concentration; D011859:Radiography; D012306:Risk; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007485:Ioxaglic Acid